PEOPLE staffers have rounded up some of our favorite books of the decade so far, in honor of PEOPLE's 50th anniversary — see ...

Here’s a look at the opioid crisis. Experts say the United States is in the throes of an opioid epidemic. An estimated 8.9 million Americans aged 12 and older misused opioids in 2023. Opioids are ...

Five Purdue Pharma LP patents covering an abuse-resistant OxyContin formulation that reduces the opiod’s toxicity are invalid ...

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help ...

Netflix scores a hit with Christmas Day NFL games, how Medicare plans, working with PBMs, fueled opioid sales, and more news ...

Wellpath, a health care provider for hospitals, prisons and jails, has been dogged by wrongful death and medical negligence ...

As the U.S. opioid crisis deepened, Medicare plans administered by UnitedHealth and CVS Health were a top source of OxyContin ...

McKinsey said in a statement on Friday that it's “deeply sorry” for its work for Purdue Pharma. “We should have appreciated the harm opioids were causing in our society and we should not ...

The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma ...

A multinational consulting firm that helped promote Purdue Pharma’s opioid medicines has reached a settlement with federal ...

For years, pharmacy benefit managers took payments from opioid manufacturers, including Purdue Pharma, in return for not restricting the flow ...

Between 2003 and 2012, Purdue Pharma paid PBMs roughly $400 million annually to avoid limits on opioid prescriptions, which included measures that could have curtailed overprescribing, such as ...